Thanks Sticky. You have to admit, if you can piece that together as even an estimate I think it would give us a better idea of what removing dailymedrx would do to their bottom line. Many people on the boards who are bashing have said it is not profitable only as the service side business because they are looking at the service side unaudited financials. However, I do not think that they have taken this concept of what we are talking about here into account that there were maybe many SGnA expenses mixed in with the service side expenses also that will now lower those expenses on the service side going forward. Even in the year end conference call they verbally stated that the service sector alone was profitable. I am guessing some of the shared expenses that are maybe not apparent in the current basic financials as far as the separation could be substantial. Of course there must have been SGnA expenses that were being carried by the service side for Dailymed that will be removed going forward. The hard part is trying to guess what amount that would be considering this is the first real quarter where it will be truely just the service sector. May even be smoke and mirrors this time, but in q2 for sure, since the sale was supposidely complete in February, would have to have it totally removed.
